Advanced Wound Care Markets Worldwide (Skin Ulcers, Burns, Surgical and Trauma, Moist Dressings, Negative Pressure, Biological Dressings, Anti-Infectives, Staples, Sutures, Cleansing, Debridement, Tapes, Other Devices)

The wound care industry is an incredibly diverse and highly competitive arena that is ever-changing. Kalorama Information feels that the market will continue to expand over the long term due to an aging population, longer life expectancies, and an increasing number of sicker patients across all care settings.

This report, Advanced Wound Care Markets, provides breakouts of the market by category, including the following:

• Skin Ulcers (Management, Moist Dressing, Negative Pressure Wound Therapy, Biological Dressings, Pressure Relief)
• Burns Wound Care Market (Anti-Infectives, Management, Moist Dressing, Biological Dressings, Pressure Relief)
• Surgical and Trauma Wounds (Wound Closure, Anti-Infectives, Moist Dressing, Biological Dressing, Miscellaneous Surgical and Trauma Wound Treatments)

The emerging generation of wound care products and technologies is well-positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.

To capture this market, Kalorama breaks out the wound market further not only by application but by type of product, with further subsegmentation within product categories:

• Moist Dressings Segment (Alginates, Hydrocolloids, Hydrogels, Films, Foams)
• Management Segment (Cleansing, Debridement, Tapes, Dry Dressings, Silver Dressings)
• Biological Dressings Segment (Artificial Skins and Collagen Products)
• Wound Closure (Sutures, Staplers and Staples; Tissue Adhesives, Sealants, and Glues)

In the short term, there will be more ebb and flow in the industry due to changes in reimbursement, contract bidding, mergers and acquisitions, and changes in the delivery of health care. Patients have more complex coexisting illnesses such as diabetes, heart failure, obesity, pulmonary and vascular diseases, immobility issues and chronic wounds. These factors are all influenced by future demographic trends, economic uncertainty, the impact of health care reform, increasing numbers of uninsured patients, reimbursement pressures from third party payers, continuing shortage of nurses and physicians and increasing technology and supply costs.

Issues and trends shaping the industry that are discussed in the report include:

• World Demographics
• Scars
• Honey Treatment
• Healthcare Reimbursement by Country
• Electronic Medical Records
• Mesenchymal Stem Cells
• Telemedicine and Wound Care
• Vitamin D
• Apps for Wound Care
• Obesity and Wound Healing
• Non-Payment Events
• Evidence Based Wound Care
• Silver Toxicity
• Home Care
• Competitive Bidding Contracts
• Medical Device Tax
• Cost Considerations
• Surgical Infection
• Wound Care Technologies
• Wound Care Clinics

The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 100 face to face, telephone and email interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

• 3M Health Care
• ABL Medical, LLC
• ACELL, INC
• Alliqua Biomedical, Inc
• Amniox Medical
• Angelini Pharma, Inc
• Argentum Medical, LLC
• ArjoHuntleigh
• Arobella Medical, LLC
• Baxter Bioscience
• B. Braun/Aesculap, Inc.
• BSN medical
• Celleration
• Coloplast A/S
• ConvaTec, Ltd.
• Covidien, Ltd
• CryoLife, Inc.
• Curaline, Inc
• Derma Sciences
• DeRoyal Industries
• EHOB, Inc
• Ethicon, Inc
• GlaxoSmithKline Plc
• Hartmann Group
• Hill-Rom Company, Inc.
• Hollister Wound Care LLC
• Integra Life Sciences
• Johnson & Johnson
• Kinetic Concepts, Inc. (KCI)
• LifeBond Ltd
• Lohmann and Rauscher GmbH
• Marine Polymer Technologies, Inc.
• Medline Industries
• MiMedx
• Molnlycke HealthCare
• MPM Medical, Inc
• Oculus Innovative Sciences, Inc
• Organogenesis, Inc
• Osiris Therapeutics, Inc
• Pfizer, Inc.
• Shire Plc
• Smith & Nephew, Plc
• Soluble Systems, LLC
• Southwest Technologies
• Spiracur, Inc
• SteadMed Medical
• Stryker Corp

Focus on Skin Ulcer Wound Care


The worldwide skin ulcer treatment market reached revenues of over 7 billion in 2013.  Revenues were based on sales at the manufacturers’ level for the following markets:

• Skin Ulcer Anti-infectives
• Skin Ulcer Management
• Skin Ulcer Moist Dressings
• Skin Ulcer Negative Pressure Wound Therapy
• Skin Ulcer Biological Dressings
• Skin Ulcer Pressure Relief Devices
• Miscellaneous Skin Ulcer Treatments

The market is varied in terms of both product offerings and product maturity.  Several of the segments within the worldwide skin treatment market are mature such as anti-infectives, skin ulcer management, and pressure relief devices, while others such as biological dressings and negative pressure wound therapy are in the growing stages of
development. Thus some segments within the market are slowing in growth rates while others are driving growth. As identified in the report, conventional, mature products continue to generate the majority of sales; however, their growth rate is slow and limited by the maturity of the product and the competition. Advancements in biotechnology,  biomaterials, and tissue engineering are expected to drive growth during the forecast period. Another area driving growth is the negative pressure wound therapy segment which increased in revenues by 10.8% over the 2011-2013 years. 

There has been an uptick in the number of companies offering NPWT which is creating pricing pressure. Over the past few years we have seen a decline in pricing. The market is expected to exhibit an overall steady growth rate due to the increasing elderly population, rising rate of disease such as diabetes and obesity, availability of new therapeutic techniques, and the recent focus on wound care products and prevention.



                                                      Many Factors in Wound Care Growth

New York, June 10, 2014 — The wound care industry is an incredibly diverse and highly competitive arena that is ever-changing. Kalorama Information feels that the market will continue to expand over the long term due to an aging population, longer life expectancies, and an increasing number of sicklier patients across all care settings. In the short term, there will be more ebb and flow in the industry due to changes in reimbursement, contract bidding, mergers and acquisitions, and changes in the delivery of health care. Patients have more complex coexisting illnesses such as diabetes, heart failure, obesity, pulmonary and vascular diseases, immobility issues and chronic wounds. These factors are all influenced by future demographic trends, economic uncertainty, the impact of health care reform, increasing numbers of uninsured patients, reimbursement pressures from third party payers, continuing shortage of nurses and physicians and increasing technology and supply costs. These market factors are discussed in detail by Kalorama Information in its report Worldwide Wound Care Markets,

According to report analyst Mary Anne Crandall, “The emerging generation of wound care products and technologies is well-positioned to capitalize on growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed.”

The top wound care companies worldwide include Johnson & Johnson, KCI, Covidien, Hill-Rom and Smith & Nephew. These companies are responsible for more than 50% of the revenues for the total market. Other key players in the market include 3M, MoInlycke, B. Braun/Aesculap, ConvaTec, Baxter International, and Hartmann.

Kalorama Information’s report, Worldwide Wound Care Markets, provides more information including breakouts for various treatment segments of the wound care market, and discussions of trends in the industry. Profiles of key competitors are also included. The report can be found at: www.kaloramainformation.com/
 
About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.